Literature DB >> 19079197

IL-22 in mucosal immunity.

W Ouyang1, P Valdez.   

Abstract

Recent studies in infectious disease and autoimmune disease models have revealed that interleukin (IL)-22 might have both proinflammatory and anti-inflammatory functions. There is, however, lack of evidence for IL-22 directly repressing immune responses of leukocytes. We propose that IL-22 promotes innate immunity of tissues, as well as repairing and healing mechanisms during inflammation. Consequently, the restoration of tissue homeostasis helps to attenuate the inflammatory responses involving various immune cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19079197     DOI: 10.1038/mi.2008.26

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  29 in total

Review 1.  Role of interleukin-22 in inflammatory bowel disease.

Authors:  Lin-Jing Li; Chen Gong; Mei-Hua Zhao; Bai-Sui Feng
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

2.  Interleukin-22 exacerbates airway inflammation induced by short-term exposure to cigarette smoke in mice.

Authors:  Jiu-rong Li; Wei-xun Zhou; Ke-wu Huang; Yang Jin; Jin-ming Gao
Journal:  Acta Pharmacol Sin       Date:  2014-10-27       Impact factor: 6.150

Review 3.  Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis.

Authors:  Maho Nagasawa; Hergen Spits; Xavier Romero Ros
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-12-03       Impact factor: 10.005

4.  Mitigation of Radiation-Induced Epithelial Damage by the TLR5 Agonist Entolimod in a Mouse Model of Fractionated Head and Neck Irradiation.

Authors:  Ilia A Toshkov; Anatoli S Gleiberman; Vadim L Mett; Alan D Hutson; Anurag K Singh; Andrei V Gudkov; Lyudmila G Burdelya
Journal:  Radiat Res       Date:  2017-03-21       Impact factor: 2.841

5.  Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections.

Authors:  Mark S Wilson; Carl G Feng; Daniel L Barber; Felix Yarovinsky; Allen W Cheever; Alan Sher; Michael Grigg; Mary Collins; Lynette Fouser; Thomas A Wynn
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

6.  Interleukin-26 Production in Human Primary Bronchial Epithelial Cells in Response to Viral Stimulation: Modulation by Th17 cytokines.

Authors:  Karlhans Fru Che; Riitta Kaarteenaho; Elisa Lappi-Blanco; Bettina Levänen; Jitong Sun; Åsa Wheelock; Lena Palmberg; C Magnus Sköld; Anders Lindén
Journal:  Mol Med       Date:  2017-08-29       Impact factor: 6.354

7.  Inflammatory monocyte recruitment is regulated by interleukin-23 during systemic bacterial infection.

Authors:  Mohanalaxmi Indramohan; Amy N Sieve; Timothy J Break; Rance E Berg
Journal:  Infect Immun       Date:  2012-09-10       Impact factor: 3.441

8.  Homeostatic PPARα Signaling Limits Inflammatory Responses to Commensal Microbiota in the Intestine.

Authors:  Indumathi Manoharan; Amol Suryawanshi; Yuan Hong; Punithavathi Ranganathan; Arulkumaran Shanmugam; Shamim Ahmad; Daniel Swafford; Balaji Manicassamy; Ganesan Ramesh; Pandelakis A Koni; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2016-04-25       Impact factor: 5.422

9.  IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking.

Authors:  Durga Sivanesan; Claudine Beauchamp; Christiane Quinou; Jonathan Lee; Sylvie Lesage; Sylvain Chemtob; John D Rioux; Stephen W Michnick
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

10.  Canonical Wnt Signaling in CD11c+ APCs Regulates Microbiota-Induced Inflammation and Immune Cell Homeostasis in the Colon.

Authors:  Daniel Swafford; Arulkumaran Shanmugam; Punithavathi Ranganathan; Mohamed S Hussein; Pandelakis A Koni; Puttur D Prasad; Muthusamy Thangaraju; Santhakumar Manicassamy
Journal:  J Immunol       Date:  2018-03-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.